ATX slips 0.36% as global technology pressure weighs on Vienna
DAX ends Monday 0.57% lower at 26,598.64 as technology stocks weigh
S&P / TSX Composite falls 0.72% as energy and materials weigh
OHB's Order Book Is Real; SATCOMBw4 Is Still a Promise
Rheinmetall's €78 Billion Backlog Runs Into a Delivery Calendar That Won't Cooperate
Allianz Wins Workplace Accolade and Broker Upgrades, but Bank of America Stays on the Fence
XRP's Roadmap Improves the Plumbing While the Money Walks Out the Door
ASML Investors Face Two Very Different Kinds of Noise
Vanguard's All-World ETF Takes In €1.2 Billion in a Week Even as Chip Stocks Stumble
Gold's Double Bind: Washington's Rate Path and Shanghai's Retreating Bulls
Wienerberger's €140 Million Self-Help Target Faces Its First Real Test
AMD Slides With Chip Peers While Closing World Labs Deal and Expanding Quantum, Cloud Ties
Deutz Chief Flags Cologne Investment as Defence Arm Reshapes Earnings Outlook
Almonty's Sangdong Ramp-Up Hits a Water Treatment Snag as Two Analysts Trim Targets
Siemens Energy Keeps Buying Back Stock While Goldman and JPMorgan Diverge on the Price
Mutares Ties Cheaper Bond Refinancing to a Portfolio Reshuffle That Still Has to Prove Itself
ams-OSRAM's Cash Pledge Meets a Skeptical Tape
SanDisk Slides as Wall Street Rethinks the AI Spending Curve
BASF Pitches 2028 Soy Launch as Jefferies Flags a Profit Gap
Infineon's Margin Test Looms Larger Than a Single Bad Session
Renk Insiders Pick Up Shares Off-Market as Order Book Swells Past EUR 7.6 Billion
Deutsche Telekom Chosen by ECB for Digital Euro Role as AI Spending and Buybacks Run in Tandem
Ocugen Has the Plant Ready and the Cash Mapped to 2028 — Now Comes the Shareholder Vote
Xiaomi's Green Aluminium Coup Overshadowed by CLSA's Deepening Profit Cut
Nokia's ASUS Patent Truce and Nordic AI Factory Bid Fail to Lift Stock as Tech Selloff Bites
Rheinmetall's Order Book Is Full — Its Cash Register Is Not
Micron Slips as Washington Tightens Chip Rules and a DRAM Lawsuit Clears Its First Hurdle
T1 Energy Trades Near-Term Pain for Long-Term Capacity
Galimedix Therapeutics outlines development plans in Alzheimer's disease at CTAD 2026
Fortescue Slides as Goldman Tallies A$2.9bn CMRG Exposure and Iron Ore Outlook Darkens
Sellas Life Sciences: SLS009 Enrollment Hits 40 as REGAL Readout Nears
PDS Biotechnology Shares Jump as Nant-Led Financing Takes Shape and Losses Narrow